NFKB1 and depressive symptom measurement: Both animal and clinical studies on depression have shown there is decreased GFAP [68,69] together with increased neuroinflammation as seen by the expression of Erk1/2 [70,71], p-p38 MAPK [72], and NF-κB [73,74].